+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Dermatomycosis Drug"

Anti Dermatomycosis Skin Drugs Companies in China - Product Thumbnail Image

Anti Dermatomycosis Skin Drugs Companies in China

  • Report
  • January 2023
  • 71 Pages
  • China
From
Anti Dermatomycosis Skin Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Anti Dermatomycosis Skin Drugs Industry Forecasts - China Focus

  • Report
  • January 2023
  • 100 Pages
  • China
From
Anti Dermatomycosis Skin Drugs Markets in China - Product Thumbnail Image

Anti Dermatomycosis Skin Drugs Markets in China

  • Report
  • January 2023
  • 221 Pages
  • China
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Anti Dermatomycosis Drug market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin conditions. Anti Dermatomycosis Drugs are used to treat fungal infections of the skin, such as athlete's foot, ringworm, and jock itch. These drugs are typically topical, and can be applied directly to the affected area. They may also be taken orally, depending on the severity of the infection. Common active ingredients in Anti Dermatomycosis Drugs include clotrimazole, miconazole, and terbinafine. Some companies in the Anti Dermatomycosis Drug market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Bayer. Show Less Read more